Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/curadev-announces-first-treatment-cycle-completion-for-the-first-patient-dosed-in-a-phase-1ab-clinical-trial-of-its-allosteric-sting-agonist-crd3874-si-in-patients-with-advanced-cancer-at-memorial-sloan-kettering-cancer-center-in-302071911.html
https://www.prnewswire.com/news-releases/curadevs-differentiated-next-generation-sting-agonist-crd3874-si-302063167.html
https://www.prnewswire.com/news-releases/europaisches-patentamt-bestatigt-das-cyclodextrin-patent-von-curadev-fur-neue-stoffzusammensetzung-855849867.html
https://www.prnewswire.com/news-releases/european-patent-office-upholds-curadevs-cyclodextrin-patent-for-new-composition-of-matter-301308941.html